Mylan's Purchase Of Matrix Will Speed Launch Of ANDAs
Acquisition of the Indian drug maker would give Mylan an edge on generic R&D and production costs as well as access to European markets.
Acquisition of the Indian drug maker would give Mylan an edge on generic R&D and production costs as well as access to European markets.